# Intracoronary Abciximab With Clearway Catheter

> **NCT00894023** · PHASE3 · TERMINATED · sponsor: **Gennaro Sardella** · enrollment: 150 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Intracoronary bolus wtih ClearWay™RX catheter
- **DRUG:** IV abciximab

## Key facts

- **NCT ID:** NCT00894023
- **Lead sponsor:** Gennaro Sardella
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2010-12
- **Final completion:** 2011-06
- **Target enrollment:** 150 (ACTUAL)
- **Why stopped:** the study was stopped because the sample size was very difficult to achieve.
- **Last updated:** 2013-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00894023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00894023, "Intracoronary Abciximab With Clearway Catheter". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00894023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*